Table 2.
Chronogram of the study
| Informed Consent | □ | |||||||||||
| Randomization | □ | |||||||||||
| Exams/Visits | After Injection | |||||||||||
| Baseline | pos-reperfusion | 3rd–5th day of reperfusion | 5th to 7th day | Up to 1 h | 12 h | 24 h | 6th to 9th day | 1 month | 3 months | 6 months | 1 year | |
| Medical visit | □ | □ | □ | □ | □ | □ | ||||||
| ALT, AST, AP, PT, aPTT and INR | □ | |||||||||||
| Total Cholesterol, LDL-cholesterol, HDL-cholesterol and Triglycerides | □ | |||||||||||
| Full blood panel, Glucose, Urea, Creatinine, Na+, K+, CRP | □ | □ | □ | □ | ||||||||
| CK-MB mass, Troponin I | □ | □ | □ | □ | □ | |||||||
| Electrocardiogram | □ | □ | □ | □ | □ | □ | □ | □ | □ | □ | ||
| Echocardiogram | □ | □ | □ | □ | □ | |||||||
| Cardiac MRI | □ | □ | ||||||||||
| Coronary angiography | □ | □ | ||||||||||
| Cells transplant | □ | |||||||||||
| Cells sample storage | □ | |||||||||||
| SF-36, Minnesota and Seattle QOL | □ | □ | □ | □ | ||||||||
| QALY Evaluation | □ | □ | □ | |||||||||
ALT and AST: alanine and aspartate aminotransferases, respectively; AP: alkaline phosphatase; INR: international normatized ratio; PT: prothrombin time; aPTT: activated partial thromboplastin time; CRP: C-reactive protein; MRI: magnetic resonance image; QOL: quality of life questionnaires; QALY: quality adjusted life year.